tetramisole has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole : An imidazothiazole that is imidazo[2,1-b][1,3]thiazole in which the double bonds at the 2-3 and 5-6 positions have been reduced to single bonds and in which one of the hydrogens at position 6 is replaced by a phenyl group.
tetramisole : A racemate comprising equimolar amounts of levamisole and dexamisole.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baugh, SD | 1 |
Morrice, JR | 1 |
Reitz, AB | 1 |
Shaw, CA | 1 |
Gregory-Evans, CY | 1 |
1 other study available for tetramisole and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Levamisole derivatives as immune modulators for the treatment of amyotrophic lateral sclerosis (ALS).
Topics: Amyotrophic Lateral Sclerosis; Cytokines; Humans; Levamisole; Tetramisole | 2023 |